Takeda looks to further its investment in its European operations

By Catherine Sturman
Whilst the threat of Brexit is seeing a large number of companies moving their operations out of the UK and Europe altogether, Takeda is looking to plac...

Whilst the threat of Brexit is seeing a large number of companies moving their operations out of the UK and Europe altogether, Takeda is looking to place further investment. The pharmaceutical company are looking to build a new manufacturing facility in Ireland, providing over 40 jobs in Dublin.

Costing up to €100 million, the manufacturing facility will be over 32,000 sq ft and encompass two storeys. It will be situated next to an existing facility, located at Grange Castle Business Park. The manufacturing plant will be committed to the ongoing development of oncology drug Ninlaro.

"Ninlaro has the potential to help European patients with relapsed multiple myeloma by removing some of the barriers that can stand in the way of optimal treatment,” commented Takeda President Christophe Bianchi.

Related stories

“With Ninlaro, our hope is that many patients will be able to continue therapy until disease progression."

The news also is highly significant, given that another pharmaceutical giant, AstraZeneca has also placed investment in a new manufacturing plant in the UK for the development of prostate cancer drug Zoladex.

However, the company is also looking at further areas of future investment. Russia, for example, has become a hot contender, where Takeda will no doubt be looking at furthering their manufacturing capabilities through new and existing partnerships.

Share

Featured Articles

UPS Healthcare Addressing Connected Logistics Needs

UPS Healthcare is meeting increased need for integrated, globally connected healthcare logistics services in Republic of Ireland, where pharma is booming

HPV Vaccine 'Protects Males from Cancers' - Global Report

As a new report shows the human papillomavirus vaccine can also protect men and boys, we take a look at HPV vaccines, and their impact on world health

Tata Consultancy Report Shows AI in Healthcare on Rise

Tata Consultancy Services AI for Business Global Study shows that three-quarters of healthcare leaders are deploying AI to drive innovation and efficiency

McKinsey: Consumers Demand Data-driven Wellness Products

Medical Devices & Pharma

SpaceX Starlink Launch Boost for Indonesia Healthcare

Technology & AI

J&J Targets Supplier Sustainability to Cut Healthcare GHGs

Sustainability